HaloVax Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Out of Business

  • Financing Rounds
  • 2

HaloVax General Information

Description

Operator of a biotechnology company intended to develop a vaccine to prevent the Coronavirus. The company's vaccine is being designed on a validated platform to provide customized T cell immunity against COVID-19, while also allowing for rapid adaptation to potential genetic drift of the virus.

Contact Information

Website
www.halovax.com
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 1 Rockefeller Plaza
  • Suite 1039
  • New York, NY 10020
  • United States
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Vertical(s)
Corporate Office
  • 1 Rockefeller Plaza
  • Suite 1039
  • New York, NY 10020
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

HaloVax Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore HaloVax‘s full profile, request access.

Request a free trial

HaloVax Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore HaloVax‘s full profile, request access.

Request a free trial

HaloVax FAQs

  • When was HaloVax founded?

    HaloVax was founded in 2020.

  • Where is HaloVax headquartered?

    HaloVax is headquartered in New York, NY.

  • What industry is HaloVax in?

    HaloVax’s primary industry is Biotechnology.

  • Is HaloVax a private or public company?

    HaloVax is a Private company.

  • What is HaloVax’s current revenue?

    The current revenue for HaloVax is .

  • Who are HaloVax’s investors?

    Rocket One and Voltron Therapeutics have invested in HaloVax.

  • When was HaloVax acquired?

    HaloVax was acquired on 09-Nov-2025.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process